Six months ago JC said buy, buy, buy EXXI when it was around $24, a few weeks later it was at $2.50. Yeah, and there are a myriad of other bad calls that dud, as well as his hack Steph Link hawk. When that moron is on TV, I move over to Bloom or FOX.
The pcyc buyout price resulted in a significant drop in the share price today. ABBV initiated a stock buy back last fall...I think it was a 5B buy back. I hope the company is buying the stock. They should help prop up the price. Did the company raise the dividend twice in anticipation of this reaction? The dividend is a major reason why many investors are holding onto the stock. There will probably will be a dead cat bounce tomorrow. HCV scripts will be out tomorrow. Hopefully that will help the stock price. It needs everything it can get.
Open a chart in Yahoo finance. Compare the mighty ABBV with PJP. Try 1 month, 3 months, 6 months, 1 year, 2 years. If ABBV can't beat the sector ETF they are clearly the wrong place to be spending money. Pitiful.
Now, go through the same exercise and compare ABBV to the mighty AGEN, Agenus has kicked their butts over 1 month, 3 months, 6 months, and 1 year time frames.
They need better leadership at the helm. They have plenty of cash, just need a businessperson at the helm.
They are a bunch of amateurs. 3 major screwups in the last year that we know about, who knows how many bad decisions that they are making behind the scenes,
And coming right after giving up so easily on merging a great company like Shire, and then starting a drug price war with Gilead that they were doomed to lose from the start.
What a bunch of amateurs.
There might be some truth to this. JNJ could be a safety net for this deal. Afterall, they do have a major interest in this drug succeeding and was willing to put a pretty huge chunk on it prior to this.
Cramer is a moron. He poo poo'd PCYC forever....his lacky Adam is the same way.
ABBV holders. You are getting a good long term deal. The key is LONG. Bob Duggan with PCYC knows what he is doing and there are a LOT of Phase 1 & Phase 2 gems in the PCYC portfolio. As you know they take a long time to pan out and I'd be willing to bet that some of these will. ABBV is looking at the long term with this deal....not the next quarter or the next 12 months...but rather then next 24-60 months. If you hang tight, you'll get your yearly dividend, you'll get good growth....and then one day it will explode.
Just my $.02
This was a great deal until 2027, in three years from now abbv will have other great products coming out. there and of course we will still have at least 3.5 billion still from Humira. This company is riding on all cylinders. Don't be fooled. A year from now this stock will be over $100.00
Sentiment: Strong Buy
the future is looking good and they continue to make money, tyne same dumb analysis continue to think they know better then one that rate running this company.. Makes me LOL
As for Humira:
— 12:08 PM ET 03/05/2015
March 5 (Reuters) - ABBVIE ( ABBV ): * Interview: AbbVie CEO says experimental version of Humira has "a fundamental
change in formulation" * Interview: AbbVie
CEO says altered form of Humira is not a "tweaked" product,
but will be clearly differentiated * Interview: AbbVie
CEO says too early to predict whether Humira patients will
eventually be switched to experimental new formulation, but that would make
sense.* Interview: AbbVie CEO says investors will be "pleasantly surprised" at
durability of Humira franchise.
Mapping the ABBV/ABT stock price over the past year...slow and
sure wins the race with ABT. Gonzalez /ABBV shooting craps with
the stockholders cash.